FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TYMLOS (abaloparatide) by Radius Health, Inc. The approval expands the product's labeling for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Tymlos (abaloparatide)

Snippet

SUPPL AP for TYMLOS (ABALOPARATIDE)